Device Trial Radar · NCT07448233
Application of Mini-Programs in Long-Term Management of Epilepsy in Rural Areas
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
20
Planned (sponsor's estimate)
Start
Dec 1, 2025
Primary completion
Nov 30, 2028
Study completion Nov 30, 2028
Sponsor
- Lead sponsor
- Xijing HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 4, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Health services research
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This project, titled " Research on the Application of Mobile Health Management Mini-Programs in Long-Term Management of Epilepsy in Rural Areas", is led by the First Affiliated Hospital of Air Force Medical University, with Jiang Wen as the principal investigator. It is a prospective, multicenter, cluster-randomized controlled trial involving 1276 patients from eight rural counties in China's northwest region. This study aims to establish a new scheme for improving epilepsy management in rural areas of Northwest China by combining remote mobile health management technology. The primary objective is to evaluate the effectiveness of the remote medical management model using a mobile health management mini-program in improving the self-management ability of rural epilepsy patients; secondary objectives include evaluating the impact of this model on patients' medication adherence, quality of life, health status, and frequency of epileptic seizures. Key components include patient and doctor interfaces for features like medication reminders, and seizure records. The trial runs from December 1, 2025, to November 30, 2028, with primary outcomes measured at 6 and12 months and secondary outcomes assessing medication adherence, quality of life, and safety.
Conditions
- Epilepsies
- Remote Management of Epilepsy in Rural Areas
Interventions
WeChat mini-program "Epilepsy Smart Monitoring System"Device
Patient Module: Real-time monitoring, medication reminders, seizure logging, educational resources. Physician Module: remote follow-up, data analytics dashboard.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Epilepsy Self Management Scale ScoreTime frame: 6 and 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Neurology, Xijing Hospital, Air Force Medical University
Xi'an, Shaanxi, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.